Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
Phase 2
2,530
about 27 years
8–65
1 site in MD
What this study is about
This trial is testing how anxiety affects the brain in children. It compares healthy kids and those with anxiety to see if certain brain changes happen before or after treatment. It uses brain scans, tests, and questionnaires to understand these connections.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Attention Bias Modification Training
- 2.Take Fluoxetine
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
fluoxetine (SSRI; increases serotonin levels in brain)
oral (Oral Capsule)
Secondary: Another secondary objective is to document relations between post-treatment changes in neurocognitive features and anxiety symptoms on the PARS following treatment with Cognitive Behavioral Therapy (CBT) or fluoxetine.
Psychiatry / Mental Health